Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:


Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Patent: 9,266,956

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,266,956
Title:Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD40 antibodies
Abstract: The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
Inventor(s): Zhang; Yongke (Palo Alto, CA), Yu; Guo-Liang (Hillsborough, CA), Zhu; Weimin (San Francisco, CA)
Assignee: Apexigen, Inc. (San Carlos, CA)
Application Number:14/613,110
Patent Claims:see list of patent claims

Details for Patent 9,266,956

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. RITUXAN rituximab Injection 103705 1997-11-26 ⤷  Try it Free 2031-04-29
Idec Pharmaceuticals Corp. RITUXAN rituximab Injection 103737 2002-02-19 ⤷  Try it Free 2031-04-29
Genentech, Inc. RITUXAN HYCELA rituximab and hyaluronidase human Injection 761064 2017-06-22 ⤷  Try it Free 2031-04-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.